10X GENOMICS (Germany) Analysis
| 1KJ Stock | EUR 13.82 0.14 1.02% |
10X GENOMICS DL is overvalued with Real Value of 11.79 and Hype Value of 13.82. The main objective of 10X GENOMICS stock analysis is to determine its intrinsic value, which is an estimate of what 10X GENOMICS DL is worth, separate from its market price. There are two main types of 10X GENOMICS's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect 10X GENOMICS's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of 10X GENOMICS's stock to identify patterns and trends that may indicate its future price movements.
The 10X GENOMICS stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and 10X GENOMICS's ongoing operational relationships across important fundamental and technical indicators.
10X |
10X Stock Analysis Notes
About 100.0% of the company shares are owned by institutions such as pension funds. The company recorded a loss per share of 0.76. 10X GENOMICS DL had not issued any dividends in recent years. 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California. 10X GENOMICS operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 852 people. For more info on 10X GENOMICS DL please contact Serge Saxonov at 925 401 7300 or go to http://www.10xgenomics.com.10X GENOMICS DL Investment Alerts
| 10X GENOMICS DL had very high historical volatility over the last 90 days | |
| The company reported the revenue of 503.71 M. Net Loss for the year was (504.02 M) with profit before overhead, payroll, taxes, and interest of 416.4 M. | |
| 10X GENOMICS DL has accumulated about 621.96 M in cash with (219.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.66. | |
| Over 100.0% of the company shares are owned by institutions such as pension funds |
10X Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.23 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate 10X GENOMICS's market, we take the total number of its shares issued and multiply it by 10X GENOMICS's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.10X Profitablity
10X GENOMICS's profitability indicators refer to fundamental financial ratios that showcase 10X GENOMICS's ability to generate income relative to its revenue or operating costs. If, let's say, 10X GENOMICS is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, 10X GENOMICS's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of 10X GENOMICS's profitability requires more research than a typical breakdown of 10X GENOMICS's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.33) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.28) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.28. Technical Drivers
As of the 31st of January, 10X GENOMICS shows the mean deviation of 3.83, and Coefficient Of Variation of 3013.38. 10X GENOMICS DL technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the entity's future prices. Please confirm 10X GENOMICS DL jensen alpha, maximum drawdown, and the relationship between the information ratio and treynor ratio to decide if 10X GENOMICS DL is priced more or less accurately, providing market reflects its regular price of 13.82 per share.10X GENOMICS DL Price Movement Analysis
The output start index for this execution was fourty-four with a total number of output elements of seventeen. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. 10X GENOMICS middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for 10X GENOMICS DL. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
10X GENOMICS Outstanding Bonds
10X GENOMICS issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. 10X GENOMICS DL uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most 10X bonds can be classified according to their maturity, which is the date when 10X GENOMICS DL has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
10X GENOMICS Predictive Daily Indicators
10X GENOMICS intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of 10X GENOMICS stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 13.82 | |||
| Day Typical Price | 13.82 | |||
| Price Action Indicator | 0.07 | |||
| Period Momentum Indicator | 0.14 |
10X GENOMICS Forecast Models
10X GENOMICS's time-series forecasting models are one of many 10X GENOMICS's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary 10X GENOMICS's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About 10X Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how 10X GENOMICS prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling 10X shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as 10X GENOMICS. By using and applying 10X Stock analysis, traders can create a robust methodology for identifying 10X entry and exit points for their positions.
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California. 10X GENOMICS operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 852 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding 10X GENOMICS to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Complementary Tools for 10X Stock analysis
When running 10X GENOMICS's price analysis, check to measure 10X GENOMICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 10X GENOMICS is operating at the current time. Most of 10X GENOMICS's value examination focuses on studying past and present price action to predict the probability of 10X GENOMICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 10X GENOMICS's price. Additionally, you may evaluate how the addition of 10X GENOMICS to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |